Name | 4-methyl-1-[3-nitro-5-(trifluoromethyl)phenyl]imidazole |
---|---|
Synonyms |
4-Methyl-1-[3-nitro-5-(trifluoromethyl)phenyl]-1H-imidazole
T5N CNJ AR CNW EXFFF& D1 1H-Imidazole, 4-methyl-1-[3-nitro-5-(trifluoromethyl)phenyl]- |
Density | 1.5±0.1 g/cm3 |
---|---|
Boiling Point | 362.6±42.0 °C at 760 mmHg |
Molecular Formula | C11H8F3N3O2 |
Molecular Weight | 271.195 |
Flash Point | 173.1±27.9 °C |
Exact Mass | 271.056854 |
PSA | 63.64000 |
LogP | 2.84 |
Vapour Pressure | 0.0±0.8 mmHg at 25°C |
Index of Refraction | 1.564 |
HS Code | 2933290090 |
---|
~24% 916975-92-3 |
Literature: NOVARTIS AG; NOVARTIS PHARMA GMBH Patent: WO2006/135619 A1, 2006 ; Location in patent: Page/Page column 4; 6 ; |
~54% 916975-92-3 |
Literature: NOVARTIS AG; NOVARTIS PHARMA GmbH Patent: WO2006/135640 A2, 2006 ; Location in patent: Page/Page column 24-25 ; |
~% 916975-92-3 |
Literature: TARGEGEN INC. Patent: WO2009/49028 A1, 2009 ; Location in patent: Page/Page column 107 ; WO 2009/049028 A1 |
Precursor 4 | |
---|---|
DownStream 1 | |
HS Code | 2933290090 |
---|---|
Summary | 2933290090. other compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |